View Article

Abstract

This study aimed to develop a gastroretentive floating drug delivery system of Calcium dobesilate using direct compression to enhance bioavailability, reduce dosing frequency, and improve patient compliance. Tablets were formulated with varying concentrations of HPMC K4M, HPMC K15M, and PVP K30 and evaluated for physical and performance parameters including hardness, friability, weight variation, drug content, buoyancy lag time, total floating time, and in-vitro drug release. All formulations met USP standards for weight variation and drug content, which ranged from 98.56?±?0.14% to 99.85?±?0.47%, indicating uniform drug distribution. The optimized formulation (F8) demonstrated 99.45% drug release over 12 hours, whereas the marketed formulation released 98.78% in just 2 hours. Kinetic modeling revealed zero-order release with an R² value of 0.924, indicating a consistent release profile. Thus, the developed floating tablets offer a promising gastro retentive system for sustained delivery of Calcium dobesilate.

Keywords

Calcium dobesilate, floating tablet, gastro retentive, total floating time

Introduction

The oral bioavailability of many drugs is limited by their unfavourable physicochemical characteristics or absorption in well-defined part of the gastrointestinal tract (GIT) referred as “absorption window” [1]. Prolonged gastric retention improves bioavailability, reduces drug waste, and improves the solubility for drugs that are less soluble in a high pH environment [2]. Various approaches have been investigated to increase the retention of oral dosage form in the stomach, including floating systems, swelling and expanding systems, bioadhesive systems, modified shape systems, high density systems, and other delayed gastric emptying devices [1]. Calcium dobesilate (calcium 2, 5- dihydroxy benzenesulfonate) is a drug used for the treatment of diabetic retinopathy and chronic venous insufficiency. Calcium dobesilate shows anti-platelet and fibrinolytic activities by inhibiting platelet activation factor (PAF) and enhancing the release of tissue plasminogen activator (tPA) and acts selectively on the capillary walls regulating their physiological functions of resistance and permeability [1-3]. The objective of the present research work was to provide gastroretentive formulation that will provide once daily, sustained release dosage form of Calcium dobesilate.

MATERIALS AND METHODS

MATERIALS

Calcium Dobesilate was received as a gift sample from Pharmaceutical company. Hydroxypropyl methylcellulose (HPMC K4M, HPMC K15M) was procured from Meditab Specialities Pvt. Ltd., Satara. PVP K30 was purchased from S.D fine chemicals, Mumbai. Sodium bicarbonate, citric acid, magnesium stearate, talc were purchased from Mapromax, Life sciences Pvt. Ltd., Dehradun. Other solvents and chemicals used in the research were of LR grade. All the studies were carried in distilled water.

METHODS

Preparation and characterization of Calcium Dobesilate of floating tablet

Direct compression was followed to manufacture the gas generating floating tablets of Calcium Dobesilate. Nine different formulations (F1, F2, F3, F4, F5, F6, F7, F8, & F9) were prepared by direct compression [6]. All the polymers selected, drug and excipients were passed through sieve no. 40 before using into formulation. The amount and ratio of drug and polymers were weighed as per given in table no.1 and all the formulation were used for further evaluations parameters.

Table 1: Various formulations of Calcium Dobesilate gastro retentive tablets

Excipients(mg)

F1

F2

F3

F4

F5

F6

F7

F8

F9

Calcium Dobesilate

500

500

500

500

500

500

500

500

500

HPMC K 5

50

75

100

-

-

-

25

37.5

50

HPMC K 16

-

-

-

50

75

100

25

37.5

50

PVP K30

10

10

10

10

10

10

10

10

10

Citric acid

5

5

5

5

5

5

5

5

5

NaHCO3

10

10

10

10

10

10

10

10

10

Mg(C18H35O2)2

5

5

5

5

5

5

5

5

5

Talc

10

10

10

10

10

10

10

10

10

Lactose

60

35

10

60

35

10

60

35

10

Total Weight

650

650

650

650

650

650

650

650

650

Determination of Bulk properties

Bulk density  

Bulk density is determined by measuring the volume of a known mass of powder sample that has been passed through a screen into a graduated cylinder or through a volumetric measuring apparatus into a cup.

Procedure

Accurately weighed 1gm of powder was poured into the measuring cylinder carefully level the powder without compacting, if necessary and read the unsettled apparent volume, Vo, to the nearest graduated unit. Calculate the bulk density in gm per ml, gm/cc by the formula.

Bulk density = Bulk Mass/ Bulk Volume

Tapped density

Tapped density is determined by measuring the volume of a known mass of powder sample before and after the tapping that has been passed through a screen into a graduated cylinder or through a volumetric measuring apparatus into a cup [7].

Procedure

Accurately weighed 10 gm of powder was poured into the measuring cylinder carefully level the powder and read the tapped volume (after 50-60 times tapping), Vt to the nearest graduated unit. Calculate the tapped density in gm per ml, gm/ cm3 by the formula:

Tapped density = Bulk Mass/ Tapped Volume

Compressibility index (Carr’s index):

Compressibility index (C.I.) is an important measure that can be obtained from the bulk and tapped densities. Carr’s index a material having values of less than 20% to 30% is defined as the free-flowing material [8].

It can be calculated as per given formula:

                                              Tapped density- Bulk density

                           C.I.   =                                                                  x100

                                                       Tapped density

Hausner ratio

It indicates the flow properties of the powder and is measured by the ratio of tapped density to bulk density.

Hausner ratio = Tapped density / Bulk Density

Evaluation of tablets

All the tablets were evaluated for following different parameters which includes;

Thickness and diameter

Thickness and diameter of tablets were determined using Vernier caliper. Five tablets from each batch were used and an average value was calculated [9].

Drug content

Twenty tablets were taken and amount of drug present in each tablet was determined [66]. The tablets were crushed in a mortar and the powder equivalent to 100 mg of drug was transferred to 100 ml standard flask. The powder was dissolved in 50 ml of 0.1 N HCl and made up to volume with of 0.1 N HCl. The sample was mixed thoroughly and filtered through a 0.45μ membrane filter. The filtered solution was diluted suitably and for drug content by UV spectrophotometer at λmax of 316 nm using of 0.1 N HCl as blank.

Hardness

For each formulation, the hardness of five tablets was determined using the Monsanto hardness tester (Cadmach).

Friability

The friability of a sample of 10 tablets was measured using a Friability tester (Electro Lab). Ten tablets were weighed, rotated at 25 rpm for 4 minutes. Tablets were reweighed after removal of fines (dedusted) and the percentage of weight loss was calculated [10].

W1 = Initial weight of tablet before test

W2 = final weight of tablet after test

Uniformity of weight

Twenty tablets were randomly selected from each batch individually weighed, the average weight and standard deviation of 20 tablets was calculated [11].

In vitro buoyancy studies

In vitro buoyancy was determined by floating lag time as per the method [12]. The tablets were placed separately in a 100 ml glass beaker containing simulated gastric fluid (SGF), pH 1.2 as per USP. The time required for the tablet to rise to the surface and float was determined as floating lag time.

In vitro dissolution rate studies

In vitro drug release of the sample was carried out using USP- type II dissolution apparatus (Paddle type) [13]. The dissolution medium, 900 ml 0.1N HCl was placed into the dissolution flask maintaining the temperature of 37±0.50ºC and at 75 rpm. One Calcium Dobesilate tablet was placed in each basket of dissolution apparatus. The apparatus was allowed to run for 12 hours. Sample measuring 5 ml were withdrawn after every 1 hour up to 12 hours using 10 ml pipette. The fresh dissolution medium (37ºC) was replaced every time with the same quantity of the sample and take the absorbance at 316 nm using spectroscopy.

RESULTS AND DISCUSSION

Direct compression was followed to manufacture the gas generating floating tablets of Calcium Dobesilate. And powder bland was evaluated for pre-compression parameters. The loose bulk density (LBD) and Tapped bulk density (TBD) of the powders of different formulations were evaluated before the compression of powders in to tablets. The bulk density and the tapped density for all the formulations varied from 0.423 to 0.438 gm/cm3 and 0.536 to 0.545 gm/cm3 respectively. The values obtained lies within the acceptable range. The difference exists between the bulk density and tapped density found to be very few. This result helps in calculating the % compressibility of the powder. The result of Hausner’s ratio of all formulations ranges from 1.237 to 1267. Results of Hausner’s ratio of all formulations were indicates that the flow ability of all the formulation. The results of the compressibility index of all the formulations ranges from 19.188% to 21.082%. Results clearly showed that the flow ability of all the formulations was good and also the powder had good compressibility table 2. The thickness of the tablets was reported in the micrometer (mm). The thickness of tablet indicates that, die fill was uniform. The thickness depends on the size of the punches (8 mm) and the weight of one tablet (650mg). The value of thickness ranges between 4.2±0.2 to 4.5±0.2 mm. Friability determines the strength of the tablets. The friability for all the formulations was below 1% indicating that the friability was within the prescribed limits. The results of friability test indicate that the tablet possesses good mechanical strength. The friability value ranges from 0.478±0.065 to 0.852±0.041. The mean hardness values were measured for all the formulation using Monsanto hardness tester. The hardness value ranges from 6.2±0.2 to 6.5±0.1 kg/cm2. Twenty tablets were randomly selected from each formulation and evaluated. The average weight of each formulation was recorded. The obtained data were almost uniform. The values of tablets average weight ranging from 642±9 to 659±7 mg. All the tablets passed weight variation test as the % weight variation was within the USP Pharmacopoeia’s limits of ±5 % of the weight. The % drug content of all the formulated tablets were found within the limit. % drug content value of drug was within 98.56±0.14% to 99.85±0.47%. The results within the range indicate uniform of mixing. The maximum drug content was found in formulation F8 table 3. Prepared optimized formulation (F8) showed the release of drug form gastroretentive formulation 99.45% after 12 hrs. and marketed formulation showed the release of 98.78% after 2 hrs table 4 & 5. When the regression coefficient values of were compared [14-15], it was observed that ‘R2’ values of zero order was maximum i.e. 0.924 hence indicating drug release from formulations was found to follow zero order kinetics table 6.

Table 2: Result of pre-compression properties of blend

Formulation

code

Bulk density(gm/ml)

Tapped density(gm/ml)

Compressibility index

Hausner ratio

F1

0.423

0.536

21.082

1.267

F2

0.432

0.545

20.734

1.262

F3

0.425

0.536

20.709

1.261

F4

0.431

0.536

19.590

1.244

F5

0.435

0.542

19.742

1.246

F6

0.436

0.544

19.853

1.248

F7

0.431

0.542

20.480

1.258

F8

0.435

0.542

19.742

1.246

F9

0.438

0.542

19.188

1.237

Table 3: Results of post compression properties of Calcium Dobesilate FGR tablets

Formulation code

Thickness* (mm)

Hardnes* (kg/cm2)

 

Weight variation* (mg)

Friability* (%)

Drug content* (%)

Total floating

duration* (h)

Floating lag times* (sec)

F1

4.2±0.2

6.2±0.2

650±5

0.754±0.002

98.89±0.23

10±1.0

45±2

F2

4.3±0.1

6.5±0.1

655±4

0.780±0.045

98.56±0.14

10±1.0

42±1

F3

4.2±0.3

6.4±0.2

648±6

0.658±0.032

98.78±0.25

11±1.0

49±3

F4

4.3±0.1

6.5±0.3

652±5

0.478±0.065

99.12±0.32

10±0.5

53±4

F5

4.2±0.4

6.4±0.2

659±7

0.698±0.074

98.69±0.25

11±1.0

56±2

F6

4.5±0.2

6.5±0.1

647±4

0.745±0.065

98.98±0.26

12±0.2

58±5

F7

4.3±0.3

6.4±0.1

642±9

0.625±0.045

98.95±0.54

12±1.0

41±4

F8

4.4±0.4

6.4±0.1

643±3

0.775±0.62

99.85±0.47

12±0.2

38±2

F9

4.4±0.5

6.5±0.1

648±4

0.852±0.041

98.74±0.58

12±0.5

46±1

*Average of three determinations (n=3)

Table 4: In-vitro drug release study of GRF tablets

Time

% Cumulative Drug Release

(hr)

F1

F2

F3

F4

F5

F6

F7

F8

F9

M.F

0.5

48.89

45.65

42.25

45.65

42.25

40.65

22.45

20.23

18.89

43.25

1

73.32

68.89

65.58

68.89

65.58

56.65

28.98

26.65

22.32

69.98

1.5

90.23

89.98

85.65

89.98

85.65

72.23

36.69

33.32

32.45

88.85

2

96.96

95.56

93.32

95.56

93.32

83.34

45.65

42.23

39.98

98.78

3

99.23

99.12

98.98

99.12

98.98

91.15

55.52

53.35

43.32

-

4

-

-

-

-

-

99.45

69.98

65.58

56.65

-

6

-

-

-

-

-

-

75.12

71.12

62.25

-

8

-

-

-

-

-

-

88.65

85.56

73.32

-

12

-

-

-

-

-

-

91.45

99.45

80.45

-

M.F-marketed Formulation

Table 5: In-vitro drug release data for optimized formulation F8

Time (h)

Square Root of Time(h)1/2

Log Time

Cumulative*% Drug Release

Log Cumulative % Drug Release

Cumulative % Drug Remaining

Log Cumulative % Drug Remaining

0.5

0.707

-0.301

20.23

1.409

74.35

1.871

1

1

0

26.65

1.602

60.02

1.778

1.5

1.225

0.176

33.32

1.659

54.42

1.736

2

1.414

0.301

42.23

1.745

44.38

1.647

3

1.732

0.477

53.35

1.800

36.88

1.567

4

2

0.602

65.58

1.885

23.35

1.368

6

2.449

0.778

71.12

1.949

11.02

1.042

8

2.828

0.903

85.56

1.971

6.55

0.816

12

3.464

1.079

99.45

1.999

0.22

-0.658

Figure 1: Cumulative % drug released Vs Time

Figure 2: Log cumulative % drug remaining Vs Time

Table 6: Regression analysis data of Calcium Dobesilate floating tablets

Batch

Zero Order

First Order

F8

0.924

0.881

CONCLUSION

Hydrodynamically balanced systems of Calcium Dobesilate with shorter lag time can be prepared by direct compression method using HPMC and NaHCO3 as gas generating agent. All the prepared tablet formulations were found to be good without capping and chipping. As the amount of polymer in the tablet formulation increases, the drug release rate decreases. Most of the designed formulations of Calcium Dobesilate displayed zero order release kinetics and drug release follows zero order kinetic model.

REFERENCES

  1. S. Shahi, A. Sonawane, S. Vanamore, and N. Zadbuke, “Formulation and in-vitro characterization of acyclovir floating matrix tablets: a factorial design study,” Journal of Applied Pharmaceutical Science, vol. 3, no. 5, p. 65, 2013.
  2. Yadav and D. Jain, “Formulation development and characterization of gastroretentive floating beads,” Asian Journal of Pharmacy and Medical Science, vol. 2, no. 1, pp. 1–10, 2012.
  3. Angehrn F. Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: an open-label, multicenter study, Current Therapeutic Research 1995; 56(4): 346-357.
  4. Casley smith JR. A double-blind trial of calcium dobesilate in chronic venous insufficiency, Angiology 1988; 39(10):853-857.
  5. Barras JP, Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review, Michal M. Vasa 1986; 15(3):200-205.
  6. D. Saritha, D. Sathish and Y. Madhusudan Rao. Formulation and Evaluation of Gastroretentive Floating Tablets of Domperidone Maleate. Journal of Applied Pharmaceutical Science 2(3); 2012:68-73.
  7. Newman AW. Micromeritics: Brittain HG; Physical Characterization of Pharmaceutical Solids. Marcel Dekker Inc, Newyork; Basel, 1995; 70; 293-294.
  8. Newman AW. Micromeritics: Brittain HG; Physical Characterization of Pharmaceutical Solids. Marcel Dekker Inc, Newyork; Basel, 1995; 70; 271-275.
  9. Wells J; Pharmaceutical Preformulation: Aulton ME; Pharmaceutics: The Science of dosage form design. 3 rd edi, Edinburg, London, Melbourne, Newyork, 1998; 247.
  10. Ajay B., Dinesh KP, Pradeep S. Studies on formulation and evaluation of floating tablets of ciprofloxacin. Int J ComprenPharma. 2010; 5(2); 1-3.
  11. Prakash RB, Neelima AK, Snehith VS, Ramesh C. Development of gastro retentive drug delivery system of cephalexin by using factorial design. ARS Pharma. 2009; 50(1); 8-24.
  12. Rosa M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994; 105(1); 65-70.
  13. Shailesh P, Laxmanbhai P, Chhaganbhai P. Floating matrix tablets of domperidone formulation and optimization using simplex lattice design. Indian J Pharm Res. 2011; 10(3); 447-55.
  14. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52:1145-49.
  15. Korsmeyer, R.W.; Gunny, R.; Peppas, N.A. Mechanism of solute release from hydrophilic polymers.Int. J. Pharm., Amsterdam, v.15, p.25-35, 1983.

Reference

  1. S. Shahi, A. Sonawane, S. Vanamore, and N. Zadbuke, “Formulation and in-vitro characterization of acyclovir floating matrix tablets: a factorial design study,” Journal of Applied Pharmaceutical Science, vol. 3, no. 5, p. 65, 2013.
  2. Yadav and D. Jain, “Formulation development and characterization of gastroretentive floating beads,” Asian Journal of Pharmacy and Medical Science, vol. 2, no. 1, pp. 1–10, 2012.
  3. Angehrn F. Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: an open-label, multicenter study, Current Therapeutic Research 1995; 56(4): 346-357.
  4. Casley smith JR. A double-blind trial of calcium dobesilate in chronic venous insufficiency, Angiology 1988; 39(10):853-857.
  5. Barras JP, Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review, Michal M. Vasa 1986; 15(3):200-205.
  6. D. Saritha, D. Sathish and Y. Madhusudan Rao. Formulation and Evaluation of Gastroretentive Floating Tablets of Domperidone Maleate. Journal of Applied Pharmaceutical Science 2(3); 2012:68-73.
  7. Newman AW. Micromeritics: Brittain HG; Physical Characterization of Pharmaceutical Solids. Marcel Dekker Inc, Newyork; Basel, 1995; 70; 293-294.
  8. Newman AW. Micromeritics: Brittain HG; Physical Characterization of Pharmaceutical Solids. Marcel Dekker Inc, Newyork; Basel, 1995; 70; 271-275.
  9. Wells J; Pharmaceutical Preformulation: Aulton ME; Pharmaceutics: The Science of dosage form design. 3 rd edi, Edinburg, London, Melbourne, Newyork, 1998; 247.
  10. Ajay B., Dinesh KP, Pradeep S. Studies on formulation and evaluation of floating tablets of ciprofloxacin. Int J ComprenPharma. 2010; 5(2); 1-3.
  11. Prakash RB, Neelima AK, Snehith VS, Ramesh C. Development of gastro retentive drug delivery system of cephalexin by using factorial design. ARS Pharma. 2009; 50(1); 8-24.
  12. Rosa M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994; 105(1); 65-70.
  13. Shailesh P, Laxmanbhai P, Chhaganbhai P. Floating matrix tablets of domperidone formulation and optimization using simplex lattice design. Indian J Pharm Res. 2011; 10(3); 447-55.
  14. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52:1145-49.
  15. Korsmeyer, R.W.; Gunny, R.; Peppas, N.A. Mechanism of solute release from hydrophilic polymers.Int. J. Pharm., Amsterdam, v.15, p.25-35, 1983.

Photo
Puspendra Singh Thakur
Corresponding author

SVN Institute of Pharmacy and Research, Swami Vivekanand University, Sagar- 470228

Photo
Ravish Kumar Sahu
Co-author

SVN Institute of Pharmacy and Research, Swami Vivekanand University, Sagar- 470228

Photo
Sheetal Yadav
Co-author

SVN Institute of Pharmacy and Research, Swami Vivekanand University, Sagar- 470228

Photo
Manish Dubey
Co-author

Department of Pharmacy, Vananchal College of Science, Babu Dinesh Singh University, Pharatiya, Garhwa, Jharkhand-822114

Photo
Mahesh Singh
Co-author

Department of Pharmacy, Vananchal College of Science, Babu Dinesh Singh University, Pharatiya, Garhwa, Jharkhand-822114

Puspendra Singh Thakur*, Ravish Kumar Sahu, Sheetal Yadav, Manish Dubey, Mahesh Singh, Formulation, Development and Evaluation of Sustained Release Tablets of Calcium Dobesilate, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 4246-4253. https://doi.org/10.5281/zenodo.15737735

More related articles
In-Vitro Evalution Of Tridax Procumbens In The Tre...
AKASH BHAGVAN AHER, SANDIP GANGDHAR LAWRE, ANUSHKA VIJAYKUMAR PHO...
Effect Of Sanctum on Cancer Progression and It’s...
Ashvini Dhurandar, Pranjal Salunke, Dr Gopalkrishna Sithaphle, Dr...
Unfolding The Potential of Dragon Fruit ...
Snehal Dadhe, Rekha Goukonde, Dr. Gajanan Sanap, ...
Formulation And Evaluation Of Harbal Gel For Acne, By Using Melaluca Alternifol...
Pravin G. Kukudkar, Chetan J. Gautam, Joyal Z. Katre, Piyush O. Katre, Paresh N. Shivhare, Rishabh M...
Formulation and Evaluation of Chewable Lozenges Containing Guava Leaves Extract ...
Sakshi Waghire, Prachi Murkute , Ashwini Pundkar, Dr.Santosh Payghan, Gayatri Vajir, ...
Related Articles
Review On: Comparative Efficacy of Ibuprofen Over Other NSAIDs...
J. B. Shinde, J. B. Shinde, U. A. Shaikh, M. K. Khan, S. B. Gaikwad, A. P. Ingole, S. D. Giram, ...
Formulation And Evaluation of a Charcoal-Based Cream for Psoriasis Management ...
Bhavana Daund, Swati Desale, Yogesh Sonawane, Vinod Bairagi, ...
Phytochemical Screening and Antibacterial Activity of Leave and Stem Extracts of...
Dr. Somesh Kumar Saxena, Pankaj Sharma, Dr. Shailesh Jain, ...
In-Vitro Evalution Of Tridax Procumbens In The Treatment Of Urolithisis...
AKASH BHAGVAN AHER, SANDIP GANGDHAR LAWRE, ANUSHKA VIJAYKUMAR PHOLANE, AVISHKAR PARSHARAM BARHATE, S...
More related articles
In-Vitro Evalution Of Tridax Procumbens In The Treatment Of Urolithisis...
AKASH BHAGVAN AHER, SANDIP GANGDHAR LAWRE, ANUSHKA VIJAYKUMAR PHOLANE, AVISHKAR PARSHARAM BARHATE, S...
Effect Of Sanctum on Cancer Progression and It’s Effective Therapeutic Activit...
Ashvini Dhurandar, Pranjal Salunke, Dr Gopalkrishna Sithaphle, Dr. Prafulla Tathe, ...
Unfolding The Potential of Dragon Fruit ...
Snehal Dadhe, Rekha Goukonde, Dr. Gajanan Sanap, ...
In-Vitro Evalution Of Tridax Procumbens In The Treatment Of Urolithisis...
AKASH BHAGVAN AHER, SANDIP GANGDHAR LAWRE, ANUSHKA VIJAYKUMAR PHOLANE, AVISHKAR PARSHARAM BARHATE, S...
Effect Of Sanctum on Cancer Progression and It’s Effective Therapeutic Activit...
Ashvini Dhurandar, Pranjal Salunke, Dr Gopalkrishna Sithaphle, Dr. Prafulla Tathe, ...
Unfolding The Potential of Dragon Fruit ...
Snehal Dadhe, Rekha Goukonde, Dr. Gajanan Sanap, ...